Location History:
- Roosevelt Island, NY (US) (2013)
- Basel, CH (2015 - 2024)
Company Filing History:
9 out of 512 
6 out of 34 
Years Active: 2013-2024
Title: The Innovative Journey of Anna Dilhas: Pioneering Advances in Androgen Receptor Modulators
Introduction: Anna Dilhas, a renowned inventor based in Basel, Switzerland, has made significant contributions to the field of pharmacology and biotechnology. With a remarkable portfolio of 10 patents, her innovative work primarily revolves around androgen receptor modulators, making strides in the development of pharmaceutical solutions for various medical conditions.
Latest Patents: Among Anna's noteworthy patents is her recent innovation, which revolves around crystalline forms of an androgen receptor modulator. Specifically, this patent describes the amorphous and crystalline forms of the androgen receptor modulator known as 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide. This patent also highlights pharmaceutical compositions suitable for mammalian administration, as well as methods to utilize the modulator, both independently and in combination with other compounds, for treating diseases linked to androgen receptor activity.
Career Highlights: Anna's career is marked by her pivotal roles at prestigious research institutions. She has been a part of the Sloan Kettering Institute for Cancer Research, where her work significantly impacted cancer research and treatment methodologies. She also contributed her expertise to Aragon Pharmaceuticals, Inc., focusing on innovative therapeutic solutions.
Collaborations: Throughout her career, Anna Dilhas has collaborated with esteemed professionals in the field. Notable among her coworkers are Ouathek Ouerfelli and Mark R Herbert, whose combined efforts have furthered advancements in the pharmaceutical sciences.
Conclusion: Anna Dilhas stands as a testament to the power of innovation in medicine. Her contributions, particularly in the realm of androgen receptor modulators, not only exemplify her ingenuity but also reflect the collaborative spirit within the research community. With her continued dedication to advancing scientific knowledge, Anna's work promises to yield significant benefits for the betterment of healthcare.